ANI PHARMACEUTICALS INC - Common Stock (ANIP)

CUSIP: 00182C103

Q3 2025 13F Holders as of 30 Sep 2025

Security identity
Shares outstanding
22,278,088
Holder snapshot
Share change
+487,978
Put/Call ratio
100%
Reported price per share
$91.60
Number of holders
266
Value change
+$52,854,102
Number of buys
142
Number of sells
107

Security key

00182C103

Report period

Q3 2025

Institutions

266

Top holders

10

Ownership snapshot

Top reported holders of ANIP - ANI PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BlackRock, Inc.
13D/G signal
BlackRock, Inc.
Evidence rows
15
Latest as of
30 Sep 2025
13D/G 13F 3/4/5 Lead comparable stake: 11% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
11%
$230,596,038
2,517,424 shares
$0 30 Sep 2025
Meridian Venture Partners II GP, L.P.
13D/G
Robert E. Brown, Jr.
4.8%
$66,419,394
1,034,570 shares
-$9,630,000 21 Aug 2025
MILLENNIUM MANAGEMENT LLC
13F 13D/G
Company
3.8%
from 13D/G
$65,502,909
1,003,876 shares
30 Jun 2025
INTEGRATED CORE STRATEGIES (US) LLC
13D/G
Millennium Management LLC
0.3%
$5,976,442
65,245 shares
-$96,309,614 30 Sep 2025
Thomas Haughey
3/4/5
Director
0.16%
$3,138,249
36,521 shares
-$1,661,972 12 Aug 2025
Jeanne Thoma
3/4/5
Director
0.11%
$2,080,002
23,405 shares
-$1,920,370 18 Aug 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
266
Shares
20,389,328
Rows available
266
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
229
Q3 2025 holders
266
Holder diff
37
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .